4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001209191-23-024388
Chief Executive Officer sold 1,170 shares at $3.65 ($4,276)
- Chief Executive Officer acquired 7,508 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Marlan D Chief Executive Officer | 2023-04-12 | Option exercise | +3,030 | 8,999 | D | ||
| Walker Marlan D Chief Executive Officer | 2023-04-12 | Option exercise | +1,010 | 10,009 | D | ||
| Walker Marlan D Chief Executive Officer | 2023-04-12 | Option exercise | +1,734 | 11,743 | D | ||
| Walker Marlan D Chief Executive Officer | 2023-04-12 | Option exercise | +1,734 | 13,477 | D | ||
| Walker Marlan D Chief Executive Officer | 2023-04-12 | Sale | −1,170 | $3.65 | $4,276 | 12,307 | D |
| Derivatives | |||||||
| Walker Marlan D Chief Executive Officer | 2023-04-12 | Option exercise · Performance Stock Units | −3,030 | 0 | D | ||
| Walker Marlan D Chief Executive Officer | 2023-04-12 | Option exercise · Restricted Stock Units | −1,010 | 0 | D | ||
| Walker Marlan D Chief Executive Officer | 2023-04-12 | Option exercise · Restricted Stock Units | −1,734 | 3,466 | D | ||
| Walker Marlan D Chief Executive Officer | 2023-04-12 | Option exercise · Performance Stock Units | −1,734 | 3,466 | D | ||
| Open-market sales · 1,170 sh · avg $3.65 · $4,276 | |||||||
Loading xslF345X04/doc4.xml…